US Material Events SEC 8-K Filings — June 09, 2026

Material Events Monitor

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

This digest analyzes 50 SEC filings from June 9, 2026, revealing a market dominated by transformative M&A, significant financial distress, and strategic realignments. A major theme is large-scale consolidation in the specialty ingredients and biotech sectors, with Ingredion's ~$5.0B acquisition of Tate & Lyle and GSK's $10.6B acquisition of Nuvalent signaling high premiums and expectations of future synergies.

Alongside these bullish moves, there is a stark contrast of corporate distress, with Getaround entering a final dissolution phase and Aditxt resorting to heavily discounted debt financing, creating pronounced risk flags. A second key theme is the aggressive use of capital markets, with multiple companies (Arch Capital, Cheniere Energy) issuing large blocks of debt, while Novanta uses a $300M equity raise to partly fund a high-multiple acquisition. Insider activity and executive changes were widespread, from routine CFO transitions at Wendy's and Grocery Outlet to the sudden exit of two senior executives at comScore, hinting at organizational stress. Forward-looking data builds a clear catalyst calendar, with major milestones including the Nuvalent/GSK deal close in Q3 2026, FDA review decisions for Nuvalent's drugs in September and November 2026, and the Ingredion/Tate & Lyle deal closing in H2 2027. The overall market sentiment is bifurcated: confident long-term bets from well-capitalized players vs. distress financing and operational failures in weaker companies.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from June 02, 2026.

Investment Signals (10)

  • GSK (via Nuvalent) (BULLISH)

    Acquiring Nuvalent for $10.6B (40% premium), with late-stage drugs having FDA decisions in Sept/Nov 2026. Deemed accretive to sales in 2027, signaling a strategically timed, high-conviction bet on oncology

  • Ingredion (BULLISH)

    Recommended $5.0B all-cash acquisition of Tate & Lyle at a 59% premium, targeting $130M annual synergies by 2030. The massive premium and leverage plan (pro forma 3.0x) show strong conviction in the strategic fit

  • Casey's General Stores (BULLISH)

    Record FY2026 EPS of $19.16 (up 30.9% YoY) and Q4 EPS surged 66.2%. Despite a flat fuel gallon outlook, the 14% dividend increase and $1B buyback authorization signal management's confidence in sustained cash flow generation

  • Novanta (BULLISH)

    Acquiring Riverpoint Medical for $1.2B (19x EBITDA) funded partly by a $300M equity raise at $140/share. The high multiple indicates a bet on high growth, but equity funding at a premium price signals a disciplined approach to deal financing

  • Getaround (BEARISH)

    Pursuing a final stockholder-approved dissolution under Delaware law, marking a complete capital loss for equity holders. The sale of its European business for ~€31.5M is a minor recovery against $239.8M in convertible notes

  • Aditxt (BEARISH)

    Issued $725K in senior secured notes with a 35% OID, consolidating existing distressed debt. The reliance on secured debt and pledging of subsidiary assets as collateral indicates severe financial strain and a high risk of default

  • Q1 2026 revenue up 58% YoY and Bitcoin hosting revenue up 178% YoY. The record hash rate and signed JV for Kati 2 provide a strong growth narrative, though construction and development risks persist, creating a high-reward/high-risk profile

  • Director resigns with no explanation or immediate replacement, a low-materiality event that signals normal corporate governance churn but provides no actionable investment signal

  • Filed a certificate of amendment to limit director/officer liability and establish exclusive forum provisions. This is a standard corporate governance move that may signal a proactive approach to reducing litigation risk but has no immediate financial impact

  • FG Nexus (BEARISH)

    Cut executive salaries from $150K to $30K while repurchasing 35% of outstanding stock. The capital allocation to buybacks during a downsizing of the digital assets business is contradictory and signals a potential lack of better growth opportunities

Risk Flags (9)

  • Pursuing final dissolution under Delaware law, winding down all operations. This is a total loss for equity holders, with the European sale proceeds providing negligible recovery against massive debt

  • Secured $725K in new notes with a 35% OID, consolidating existing debt from March and April. The heavy discount and collateralization of subsidiary assets signal imminent liquidity crisis and high default probability

  • Director Matan Fattal resigned, leaving the audit committee with <3 members and lacking a majority of independent directors. Without a quick replacement, the company faces potential delisting from Nasdaq

  • Q3 2025 net income fell to $0.8M from $1.3M YoY, and Core FFO dropped to $0.47 from $0.50. Same-store expense growth (3.5%) outpaced revenue growth (2.0%), compressing margins and signaling operational headwinds

  • Raised only $1.485M via a private placement with warrants, indicating weak investor demand. The offering structure suggests the company faces significant cash burn and may require further dilutive capital

  • Extended merger deadline with Kuva Labs to July 17, 2026, with a potential $1.5M fee for a further extension. Lack of committed financing introduces significant uncertainty about the merger's completion, creating downside risk for both stocks

  • $10M PIPE with Smart Dynamics is subject to stockholder approval and a Nasdaq extension, creating closing risk. The heavy reliance on insider participation (Alset increasing to 80.5%) is a double-edged sword that signals insider support but also high ownership concentration risk

  • COO and Head of Measurement departed immediately, with CEO absorbing responsibilities. The unexplained, simultaneous exit of two top executives points to potential restructuring or internal strife, creating operational uncertainty

  • Nuburu/Execution Risk [MODERATE RISK]

    Head of Terms for a €1M investment with SunCubes is subject to Italian Golden Power clearance and export licenses by Dec 30, 2026. The speculative nature of the 'Laser Arm' system and reliance on foreign regulatory approvals create a high risk of non-completion

Opportunities (8)

  • GSK/Oncology Pipeline (OPPORTUNITY)

    Acquiring Nuvalent's late-stage ROS1 and ALK inhibitors with FDA PDUFA dates in Sept/Nov 2026. If approved, zidesamtinib and neladalkib could become standard of care in non-small cell lung cancer, driving significant revenue growth from 2027 onwards

  • The $1.2B acquisition of Riverpoint Medical is expected to double recurring medical consumables revenue to ~$300M and be immediately accretive to margins. The high multiple suggests strong growth potential in a high-margin, recurring revenue business

  • Casey's General Stores/Shareholder Returns (OPPORTUNITY)

    Record FY2026 results with EPS growth of 30.9% and a 14% dividend increase, coupled with a $1B share repurchase authorization. The combination of strong operational performance and shareholder-friendly capital allocation provides a compelling total return opportunity

  • Q1 revenue up 58% YoY, Bitcoin hosting up 178% YoY, with a definitive JV for Kati 2 and a 300-acre land purchase for Dorothy 3. The high-growth narrative in Bitcoin hosting and HPC infrastructure is gaining traction if execution continues

  • The $5.0B acquisition of Tate & Lyle targets $130M in annual net cost synergies by 2030. The 59% premium reflects a high bar, but if achieved, the combined entity would have significant pricing power and margin expansion potential in specialty ingredients

  • Director resigned for no stated reason, but no replacement or further disclosure. This is a non-event for investment, but could be a watch item for any future insider selling patterns at this early-stage clean fuels company

  • Appointed veteran media executive David Haddad to the board. While low materiality for immediate performance, it strategically positions the company with expertise from Warner Bros. and Activision, potentially aiding in its connected TV and gaming ad strategy

  • Passed 2026 AGM proposals with strong support, including 98.6% approval on executive compensation. The new equity plan with a one-year minimum vesting period aligns management interests with long-term shareholder value, and the removal of liberal share recycling is a positive governance move

Sector Themes (6)

  • Consolidation in Life Sciences & Ingredients

    Two major transformative M&A deals (GSK-Nuvalent, Ingredion-Tate & Lyle) signal a strong appetite for large-scale, premium-valued acquisitions in the biotech and specialty ingredients sectors. Both deals are structured around future synergies and potential blockbuster products, indicating a strategic bet on long-term growth over short-term cost savings.

  • Financial Distress vs. Capital Abundance

    A clear bifurcation exists between well-capitalized firms issuing debt and equity on favorable terms (Arch Capital $2B, Cheniere $1.75B, Novanta $300M) and distressed companies resorting to heavily dilutive or secured debt financing (Aditxt 35% OID, Aspira small raise). This highlights a 'flight to quality' in capital markets.

  • Executive Turnover as a Signal

    A wave of executive changes, from routine CFO transitions (Wendy's, Duos Technologies) to sudden departures (comScore) and board resignations (Renatus, Open Lending), suggests a period of organizational stress and strategic pivots. The volume and nature of departures (especially unexplained ones) warrant investor scrutiny.

  • Capital Return vs. Reinvestment

    Companies with strong cash flows like Casey's General Stores are returning significant capital to shareholders via dividends and buybacks. In contrast, companies in growth or turnaround modes (Soluna, Novanta) are deploying capital into M&A and capex. This split shows a 'haves and have-nots' dynamic in terms of free cash flow generation.

  • SPACs in Transition

    The SPAC sector remains active but bifurcated, with successful de-SPAC mergers progressing (Live Oak-Teamshares, QuasarEdge-Robseek) despite regulatory hurdles, while others (Renatus) face compliance issues. The market is rewarding SPACs that execute cleanly and penalizing those with governance gaps.

  • Regulatory Overhang as a Key Catalyst/Risk

    Several deals and financings are explicitly tied to regulatory milestones (Nuvalent FDA decisions, Nuburu Italian Golden Power, HWH Nasdaq extension). This creates a clear catalyst calendar but also introduces binary risk outcomes, making precise timing and regulatory assessment critical for investors.

Watch List (8)

  • Nuvalent (via GSK)
    👁

    FDA PDUFA for zidesamtinib (ROS1) in September 2026 and neladalkib (ALK) in November 2026. Approval would be a massive catalyst; rejection would question the $10.6B deal rationale.

  • Extraordinary General Meeting on June 16, 2026, to vote on business combination with Teamshares. Non-redemption agreements are in place, but actual shareholder redemption levels will be critical for deal completion and post-merger float.

  • Lisata Therapeutics (LSTA)
    👁

    Merger with Kuva Labs has a July 17, 2026 outside date, extendable to Aug 17 on payment of a $1.5M fee. Watch for financing updates or termination announcements, as the lack of committed funding is a major risk.

  • Must fill the audit committee vacancy left by Matan Fattal's resignation to regain Nasdaq compliance. Watch for the appointment of a new independent director within the cure period.

  • HWH International (HWH)
    👁

    Stockholder vote on the $10M PIPE with Smart Dynamics and Nasdaq extension request. The outcome will determine the company's liquidity and ability to continue as a going concern.

  • Soluna Holdings (SLNH)
    👁

    Watch for updates on Project Kati 1B construction and the execution of the definitive JV for Kati 2. Q2 2026 results will be key to measure if the 58% YoY revenue growth trajectory is maintained.

  • Arch Capital Group (ACGL)
    👁

    The newly issued $2B in senior notes (5.95% 2056 notes) will increase leverage modestly. Watch for deployment of proceeds (potential M&A or buybacks) in upcoming quarters.

  • Getaround (GETR)
    👁

    Monitor for dissolution filings and any creditor lawsuits, but the stock is effectively worthless. This serves as a cautionary tale for distressed companies in the sharing economy.

Filing Analyses (50)
Nuvalent, Inc. 8-K mixed materiality 10/10

09-06-2026

GSK plc announced a definitive agreement to acquire Nuvalent, Inc. for $10.6 billion ($124 per share in cash), representing a 40% premium to the last closing price. The deal includes two late-stage, potential best-in-class ROS1 (zidesamtinib) and ALK (neladalkib) inhibitors for non-small cell lung cancer currently under FDA review with target decision dates in September and November 2026, plus a phase I HER2 inhibitor (NVL-330). The acquisition is expected to be accretive to sales and core operating profit in 2027 and core EPS in 2029, but will cause low single-digit percentage dilution to core EPS for FY 2026, FY 2027, and FY 2028.

  • · The transaction is expected to close in Q3 2026, subject to tender of a majority of Nuvalent's Class A shares and HSR Act clearance.
  • · GSK will assume Nuvalent's existing revenue-sharing arrangements of low-single-digit royalties payable to Royalty Pharma and Deerfield.
  • · The acquisition will be funded primarily from new and existing debt facilities plus cash, with no impact expected to GSK's credit rating.
  • · GSK reaffirmed its 2026 dividend of 70p and progressive dividend policy.
  • · GSK's FY 2026 guidance of 7-9% core operating profit and core EPS growth remains unchanged.
  • · GSK expects low single-digit percentage dilution to core EPS for FY 2026, FY 2027, and FY 2028 from the transaction.
  • · The acquisition is expected to be accretive to core operating profit in 2027 and core EPS in 2029 inclusive of synergies and reprioritisation.
  • · Zidesamtinib has a target FDA decision date of 18 September 2026; neladalkib has a target decision date of 27 November 2026.
  • · Both zidesamtinib and neladalkib have received FDA Breakthrough Therapy and Orphan Drug Designations.
  • · The deal includes Nuvalent's preclinical portfolio of multiple programmes.
NOVANTA INC 8-K positive materiality 9/10

09-06-2026

Novanta Inc. announced a definitive agreement to acquire Riverpoint Medical for $1.2 billion upfront plus a $250 million milestone payment in Q1 2027, expected to close in Q3 2026. The acquisition is immediately accretive to Novanta's revenue growth, Adjusted Gross and EBITDA margins, Adjusted Diluted EPS, and Operating Cash Flows, and is projected to double recurring medical consumables revenue to approximately $300 million. However, the upfront purchase price of $1.2 billion represents approximately 19x Riverpoint's estimated 2026 Adjusted EBITDA excluding synergies, indicating a high valuation multiple, and the transaction will increase Novanta's net leverage ratio to approximately 2.7x post-closing.

  • · Riverpoint Medical will be reported under Novanta's Medical Solutions operating segment.
  • · Novanta expects net leverage ratio of approximately 2.7x after closing, reducing to below 2.3x by year-end 2027.
  • · Transaction financed through cash on hand, existing credit facility, and a $300 million equity raise.
  • · Novanta confirms its previously issued Q2 and Full Year 2026 financial guidance for the standalone company and will update guidance post-close.
  • · Conference call scheduled for June 9, 2026 at 8:30 a.m. ET.
  • · Riverpoint has manufacturing operations in Portland, Oregon and San Jose, Costa Rica.
Brand Engagement Network Inc. 8-K neutral materiality 7/10

09-06-2026

Brand Engagement Network Inc. (BEN) entered into a definitive agreement on June 8, 2026, to form INTERVENT Health AI, Inc., a 50/50 healthcare AI joint venture with INTERVENT International, LLC. The JV will develop AI-powered health coaching solutions combining BEN's conversational AI with INTERVENT's clinically validated methodologies and datasets. BEN, through its subsidiary SKYE AI USA, will receive 35% of certain JV revenues from North American commercialization under a five-year exclusive arrangement, while the JV will receive 50% of gross revenues from proposed non-exclusive international reseller deals in Latin America and Africa. No financial performance metrics or revenue projections were disclosed, and the agreement is subject to performance milestones.

  • · The JV's Board of Directors will consist of one BEN-appointed director, one INTERVENT-appointed director, and one mutually agreed independent director.
  • · The Shareholder Agreement includes customary governance, pre-emptive rights, and ownership protection provisions, including restrictions on issuances that would reduce either founding shareholder below specified ownership thresholds without approval.
  • · BEN is an emerging growth company as defined under SEC rules.
  • · The agreement is subject to performance milestones for the five-year exclusive North American arrangement.
Verde Clean Fuels, Inc. 8-K neutral materiality 3/10

09-06-2026

Verde Clean Fuels, Inc. announced on June 9, 2026, the resignation of director Martijn Dekker, effective June 3, 2026. The departure is a routine board change and no reasons or immediate replacements were disclosed.

  • · The resignation was effective immediately on June 3, 2026.
  • · Item 5.02(b) disclosure relates to director departure; no election of a replacement director was announced.
Getaround, Inc 8-K negative materiality 10/10

09-06-2026

Getaround, Inc. (suffering severe financial distress) disclosed the sale of its European business to GoMore ApS for ~€31.5 million in cash and a promissory note (closing April 30, 2026) and a $121.7 million reduction of senior secured debt with Mudrick Capital. However, the company has now decided to pursue a stockholder-approved dissolution under Delaware law (Section 275), winding down all operations. While the sale provided modest liquidity, the core U.S. car-share business was previously shut down, and the company remains burdened by $239.8 million of convertible notes and a new $3 million super-priority note (at 15% interest) that will be satisfied only through liquidation.

  • · U.S. business operations wind-down was approved by Board on February 7, 2025.
  • · Sale of European business closed on April 30, 2026, effective from that date.
  • · Mudrick agreed to convert portion of Convertible Notes into common stock to facilitate dissolution.
  • · New SPN matures on April 30, 2027, and carries a 15% annual interest rate (17% upon default).
  • · The company must prepay the New SPN with 100% of net proceeds from any asset sale or disposition.
  • · The dissolution proposal requires stockholder approval at a special meeting.
  • · Proxy statement for dissolution will be filed with SEC as soon as practicable.
MICRON TECHNOLOGY INC 8-K neutral materiality 3/10

09-06-2026

Micron Technology has appointed Dr. Alexis Black Björlin to its board of directors, effective June 9, 2026. Dr. Björlin is a seasoned technology executive with expertise in AI infrastructure, cloud platforms, and semiconductors. No financial terms were disclosed, and no director departures or other negative changes were announced in this filing.

Bluejay Diagnostics, Inc. 8-K neutral materiality 6/10

09-06-2026

Bluejay Diagnostics, Inc. held its 2026 annual meeting on June 9, 2026, where stockholders approved a reverse stock split authorization (ratios 1:2 to 1:20) and an amendment to the 2021 Stock Plan increasing reserved shares by 600,000. All five director nominees were re-elected, and the appointment of Wolf & Company, P.C. as independent auditor was ratified. The company noted it currently complies with Nasdaq listing requirements and has no immediate intention to implement the reverse split.

  • · The reverse stock split authorization allows ratios from 1-for-2 to 1-for-20, with the board having discretion on implementation until June 9, 2027.
  • · The board has no present intention to implement the reverse split within the next 12 months.
  • · Proposal 2 (reverse split) received 262,891 votes for, 150,322 against, and 879 abstentions.
  • · Proposal 3 (stock plan amendment) received 135,750 votes for, 94,058 against, 1,160 abstentions, and 183,124 broker non-votes.
  • · Proposal 4 (ratification of auditor) received 389,052 votes for, 21,067 against, and 3,973 abstentions.
  • · The company is an emerging growth company and has not elected to use the extended transition period for new accounting standards.
CASEYS GENERAL STORES INC 8-K mixed materiality 9/10

09-06-2026

Casey's General Stores reported record fiscal year 2026 results with diluted EPS of $19.16 (up 30.9% YoY) and net income of $714.4 million (up 30.7% YoY). Fourth quarter diluted EPS surged 66.2% to $4.37, driven by strong inside same-store sales growth of 5.5% and fuel gross profit up 29.1%. However, operating expenses increased 10.1% in Q4, and the company guided for flat-to-negative same-store fuel gallons in fiscal 2027 (-1% to +1%). The Board increased the quarterly dividend by 14% to $0.65 per share and authorized a $1 billion share repurchase program expansion.

  • · Inside margin improved 120 bps YoY in Q4 to 42.4%.
  • · Prepared food and dispensed beverage same-store sales grew 6.6% in Q4 (FY2026: 5.2%).
  • · Grocery and general merchandise same-store sales grew 5.1% in Q4 (FY2026: 3.9%).
  • · Fuel gallons sold increased 3.6% in Q4 to 848.3 million gallons.
  • · Renewable fuel credits (RINs) generated $15.2 million in Q4, up $10.8 million YoY.
  • · Same-store labor hours were approximately flat in Q4.
  • · Net cash provided by operating activities was $1.38 billion in FY2026, up from $1.09 billion.
  • · Capital expenditures (property and equipment) were $655.9 million in FY2026.
  • · Total debt and finance lease obligations (net of current maturities) were $2.33 billion at April 30, 2026.
  • · The company repurchased $200.5 million of stock in FY2026.
  • · FY2027 guidance: inside same-store sales +2% to +5%, inside margin above 42%, same-store fuel gallons -1% to +1%, total operating expenses +5% to +7%, EBITDA +8% to +10%, tax rate 24% to 26%.
  • · The company opened 40 new stores and acquired 40 stores in FY2026, while closing 41.
  • · Basic weighted average shares outstanding declined to 36.94 million in Q4 FY2026 from 37.13 million in Q4 FY2025.
FG Nexus Inc. 8-K mixed materiality 7/10

09-06-2026

FG Nexus Inc. reduced the annual base salaries of two Digital Assets Division executives, Jose Vargas (Head of Business Development) and Theodore Rosenthal (President), from $150,000 to $30,000 each, effective May 11, 2026, reflecting the company's reduced scale of operations in its digital asset business. Concurrently, the company disclosed significant share repurchase activity, having bought back 35% of its outstanding common stock and 30% of its Series A Preferred Stock through June 5, 2026. However, the company's cash and digital asset holdings of $36.1 million and $20.3 million, respectively, indicate a substantial capital allocation to buybacks amid a downsizing digital asset segment.

  • · The salary reductions were effective May 11, 2026, and the modifications were signed on June 3, 2026.
  • · Average repurchase price for common stock was approximately $13.62 per share, and for Series A Preferred Stock approximately $24.97 per share.
  • · The company held 3,375 ETH and 7,569 Wrapped stETH as digital assets valued at $20.3 million as of June 5, 2026.
Lionheart Holdings 8-K neutral materiality 5/10

09-06-2026

Lionheart Holdings appointed Freddy J. Martinez (age 70) as a Class III director effective June 6, 2026, filling a new board vacancy. The appointment reflects the Company's strategic shift to focus on oil and gas opportunities in Venezuela. Mr. Martinez brings over 40 years of investment management and energy sector experience, with no cash compensation paid for his services.

  • · Mr. Martinez is independent under NASDAQ rules and serves as President/CEO of Forem Investments LLC, a registered investment adviser founded in December 2013.
  • · He holds an MBA in finance from Wharton, an M.S. in Engineering from the Moore School, and a B.S. in Mechanical Engineering from Universidad Simón Bolívar.
  • · The Company's definitive proxy statement for an extension of time through March 20, 2027 was mailed to shareholders of record as of May 15, 2026; a special meeting is scheduled for June 15, 2026.
  • · Mr. Martinez has not received any cash compensation; he entered into a standard director indemnification agreement and the Letter Agreement dated June 17, 2024.
Inflection Point Acquisition Corp. III 8-K neutral materiality 7/10

09-06-2026

Inflection Point Acquisition Corp. III (IPCXR) filed an 8-K on June 9, 2026, announcing a business combination with Air Water Ventures Holdings Limited. The filing includes an investor presentation dated June 2026 that outlines the proposed merger, forward-looking statements, and risk factors. No specific financial metrics or performance data were disclosed in the filing.

  • · The filing includes Items 1.01 (Material Agreement Entry), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits).
  • · The investor presentation is dated June 2026 and is provided as Exhibit 99.1.
  • · The business combination involves Air Water Ventures Limited as PubCo.
  • · The filing contains extensive disclaimers regarding forward-looking statements and no offer of securities.
FutureCorp Space Acquisition 1 8-K positive materiality 8/10

09-06-2026

FutureCorp Space Acquisition 1, a blank check company focused on the global space economy, announced the pricing of its $200,000,000 initial public offering of 20,000,000 units at $10.00 per unit. The units are expected to begin trading on the NYSE on June 5, 2026, under the ticker 'FTRAU', with the offering closing on June 8, 2026. The company has granted underwriters a 45-day option to purchase up to an additional 3,000,000 units to cover over-allotments.

  • · The company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
  • · The company's primary focus will be on companies in the global space economy and adjacent industries, including space manufacturing and component supply chains, launch platforms, in-orbit services and habitats, in-orbit computing and manufacturing, space-based telecommunications and Earth observation, and defense-related activities.
  • · The registration statement relating to the securities became effective on June 4, 2026.
  • · The units are expected to be listed on NYSE under the ticker symbol 'FTRAU'.
  • · Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on NYSE under the symbols 'FTRA' and 'FTRAW', respectively.
  • · An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering.
  • · No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
Qorvo, Inc. 8-K neutral materiality 6/10

09-06-2026

On June 4, 2026, Qorvo's Compensation Committee approved FY2027 performance-based restricted stock unit (PBRSU) awards for named executive officers, with 50% tied to non-GAAP operating income, 25% to gross margin, and 25% to revenue objectives. The committee also granted a retention award to Philip J. Chesley comprising 9,618 service-based RSUs and 9,618 PBRSUs linked to organic HPA revenue growth. The awards reflect shareholder feedback from the 2025 say-on-pay vote, removing prior objectives-based metrics. The fair market value per share was set at $103.97.

  • · The FY2027 PBRSUs use three performance metrics: non-GAAP operating income (50% weight), gross margin (25%), and revenue (25%).
  • · The non-GAAP operating income and gross margin objectives are measured over three one-year periods (FY2027, FY2028, FY2029); the revenue objective is measured over a single one-year period (FY2029).
  • · Each officer can earn up to 200% of target PBRSUs for each metric if objectives are fully met.
  • · The Retention Award for Mr. Chesley includes 9,618 service-based RSUs vesting in two equal annual installments and 9,618 PBRSUs tied to organic HPA revenue growth over FY2027 and FY2028.
  • · The Retention Award PBRSUs have a maximum payout of 100% of target (not 200%).
  • · The Retention Award RSUs (but not PBRSUs) will fully vest upon a qualifying termination in connection with a change in control.
  • · Upon the closing of the merger with Skyworks, the Retention Award PBRSUs will remain in place and eligible to be earned post-closing, not measured at closing.
  • · The fair market value per share for both awards was $103.97, based on the June 4, 2026 closing price.
  • · The awards were approved in response to shareholder feedback from the 2025 say-on-pay vote, removing prior objectives-based metrics.
BRILLIANT N.E.V. CORP. 8-K neutral materiality 7/10

09-06-2026

Brilliant N.E.V. Corp. filed an 8-K on June 9, 2026, covering Items 5.01 (Change in Control), 5.02 (Departure of Directors or Principal Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). The filing indicates significant corporate governance changes, including a change in control and officer/director departures, but no specific financial figures or period-over-period comparisons were provided in the filing metadata.

  • · The company was formerly known as Clancy Corp (filings through 2023-08-09).
  • · The company's SIC code is 2840 (Soap, Detergent, Cleaning Preparations, Perfumes, Cosmetics).
  • · Fiscal year ends July 31.
  • · The filing includes items related to changes in control, officer/director changes, and amendments to governing documents.
DUOS TECHNOLOGIES GROUP, INC. 8-K neutral materiality 5/10

09-06-2026

Duos Technologies Group, Inc. announced that effective June 8, 2026, Leah Brown stepped down as Chief Financial Officer to resume her previous role as Senior Vice President of Accounting, and Adrian Goldfarb was appointed Interim Chief Financial Officer. Mr. Goldfarb, who previously served as CFO from April 2024 to November 2025 and from 2015 to 2022, will lead a search committee to hire a permanent CFO, with a replacement expected within 60 to 90 days. The filing does not disclose any financial results or performance metrics, so no positive or negative financial trends are reported.

  • · Adrian Goldfarb has been serving as Strategic Advisor to the CEO since November 2025 and as President of Duos Technologies, Inc. since March 2026, overseeing the rail industry subsidiary's operations and planned divestment.
  • · Mr. Goldfarb previously served as CFO from April 2024 to November 2025 and from 2015 to 2022, and as a Director from April 2010 to November 2020.
  • · He managed the Company's listing on the Nasdaq Capital Market in 2020.
  • · Mr. Goldfarb currently serves as non-Executive Chairman of GelStat Corporation.
  • · Prior to Duos, he served as CFO for Ecosphere Technologies, overseeing growth from $0 to $24 million and profitability.
Aeon Acquisition I Corp. 8-K neutral materiality 5/10

09-06-2026

Aeon Acquisition I Corp. adopted a Second Amended and Restated Memorandum and Articles of Association on June 2, 2026, filed via an 8-K on June 9, 2026. The updated governing documents formalize the company's structure as a Cayman Islands exempted company limited by shares, with an authorized share capital of $50,000 divided into 450,000,000 Class A ordinary shares, 45,000,000 Class B ordinary shares, and 5,000,000 preference shares, all at $0.0001 par value. The company is designated as a special purpose acquisition company (SPAC) with a 12-month (extendable to 18-month) completion window to consummate a business combination valued at least 80% of trust assets, and it retains the power to register by continuation outside the Cayman Islands.

  • · The company is incorporated in the Cayman Islands with registered office at Cassia Court, Suite 716, 10 Market Street, Camana Bay, Grand Cayman KY1-9006.
  • · The financial year end is December 31.
  • · The company has the power to register by continuation as a body corporate under the laws of any jurisdiction outside the Cayman Islands.
  • · The business combination must involve a target business with an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding deferred underwriting commissions and taxes on interest income).
  • · The company may not effectuate a business combination solely with another blank check company or similar company with nominal operations.
  • · The Over-allotment Option allows underwriters to purchase up to an additional 15% of the units issued in the IPO at $10 per unit, less underwriting discounts and commissions.
  • · The company is prohibited from issuing shares to bearer.
NUSATRIP Inc 8-K mixed materiality 7/10

09-06-2026

NusaTrip Inc. announced multiple executive changes on June 2, 2026, including the appointment of Loïc Gautier as CFO (annual base salary $150,000), Binglin Yu as CTO (RMB 55,000/month), and Hongwei Zhang as Chief Revenue Officer (RMB 55,000/month, effective June 20). The company also removed COO Ade Irawan effective June 2, and entered into an employment agreement with CEO Patrick Soetanto Tjin (base salary $150,000/year plus minimum 25% performance bonus). Notably, the previously announced CFO appointment of Wallace Tzi Chun Foo did not proceed due to personal reasons.

  • · CFO appointment of Wallace Tzi Chun Foo did not become effective due to personal and family reasons; no disagreement with the company.
  • · New CFO Loïc Gautier has over 10 years of experience in technology, e-commerce, and corporate finance in Southeast Asia; founded Leflair, acquired by SOPA in 2021; helped SOPA with its Nasdaq IPO in 2022.
  • · New CTO Binglin Yu holds a Bachelor of Science in Computer Science and Technology from Peking University.
  • · New CRO Hongwei Zhang holds an MBA from Pennsylvania State University and is fluent in English and Mandarin.
  • · Former COO Ade Irawan was removed from all officer, management, banking, administrative, platform access, and other authorized capacities with the company and its subsidiaries.
  • · CEO Patrick Soetanto Tjin's employment agreement includes a minimum 25% performance bonus based on base salary.
  • · CRO Hongwei Zhang previously worked at INTECH TRAVEL GROUP, a principal airline content supplier to NusaTrip, from November 2023 to September 2025.
Cocrystal Pharma, Inc. 8-K neutral materiality 6/10

09-06-2026

Cocrystal Pharma, Inc. appointed James Sapirstein as CEO effective June 3, 2026, replacing co-CEOs Sam Lee and James Martin. Mr. Sapirstein receives a $265,000 base salary, a 50% performance bonus, and an initial grant of 235,000 stock options at $1.05 per share, with a potential additional grant of 235,000 options after six months. Sam Lee remains President and Chief Scientific Officer, and James Martin continues as CFO.

  • · James Sapirstein previously served as CEO of Entero Therapeutics from October 2019 to February 2025 and as a consultant from February 2025 to March 2026.
  • · The initial option grant vests in four equal annual installments beginning June 3, 2027, with full acceleration upon a Change in Control and 50% acceleration upon termination without Cause.
  • · The potential additional option grant is subject to continued employment, performance targets, and Compensation Committee approval, with an exercise price equal to the closing price on the grant date.
22nd Century Group, Inc. 8-K negative materiality 6/10

09-06-2026

22nd Century Group, Inc. filed an 8-K announcing stockholder approval of a 1-for-20 reverse stock split, effective at 12:01 a.m. on June 12, 2026. The reverse split reduces the number of issued and outstanding shares of common stock without adjusting par value or reducing authorized shares. Fractional shares will be rounded up to the nearest whole share.

  • · Reverse stock split effective date: June 12, 2026 at 12:01 a.m.
  • · Par value remains $0.00001 per share; authorized shares unchanged.
  • · Fractional shares resulting from the split will be rounded up to the nearest whole share.
  • · Old certificates will represent the post-split number of whole shares until surrendered.
Aspira Women's Health Inc. 8-K negative materiality 7/10

09-06-2026

Aspira Women's Health Inc. entered into securities purchase agreements on June 5, 2026, for a private placement generating gross proceeds of approximately $1.485 million. The offering includes 3.3 million shares of common stock and warrants to purchase up to 4.455 million shares at an exercise price of $0.75 per share. Net proceeds will be used for working capital and general corporate purposes.

  • · The common warrants are exercisable immediately upon issuance and have a term of three years.
  • · The purchase agreement includes customary representations and warranties, conditions to closing, termination provisions, and an anti-dilutive provision.
  • · The company granted purchasers customary registration rights for the shares and shares underlying the warrants.
  • · The private placement was conducted with accredited and institutional investors.
LISATA THERAPEUTICS, INC. 8-K mixed materiality 8/10

09-06-2026

Lisata Therapeutics entered into an amendment and waiver to its merger agreement with Kuva Labs, extending the offer commencement deadline and outside date, and receiving delayed interim operating payments totaling $250,000. The amendment also adds a representation by Parent regarding financial ability to fund the merger, including a non-binding indication of interest for up to $25 million in convertible notes. However, the lack of committed financing and the extension of deadlines introduce uncertainty about the merger's completion.

  • · The original merger agreement was dated March 6, 2026.
  • · The offer commencement deadline was extended from 60 business days after March 6 to 65 business days.
  • · The outside date was extended from July 6, 2026 to July 17, 2026, with a possible further extension to August 17, 2026 upon payment of a $1.5 million extension fee.
  • · Parent and Purchaser represent they have a reasonable, good faith belief that anticipated funding sources will be sufficient, but acknowledge no binding commitments exist.
  • · The waiver includes a covenant not to sue during the waiver period (June 8 to June 10, 2026) and conditional waivers of claims related to delayed offer commencement and missed interim operating payment.
  • · If Parent fails to make interim payments or commits a material breach, the Company may terminate Sections 2, 3, and 4 of the waiver.
Soluna Holdings, Inc 8-K mixed materiality 8/10

09-06-2026

Soluna Holdings reported Q1 2026 revenue up 58% YoY, with Bitcoin hosting revenue up 178% YoY and a record hash rate, marking the fourth consecutive quarter of growth. However, the company also disclosed ongoing construction and development risks, including transformer repairs at Project Dorothy 1A that were completed in May, and noted that Project Kati 1B construction is still ongoing with Phase 3 ahead of schedule. The company regained Nasdaq compliance and signed a definitive JV agreement for Kati 2, but tenant due diligence and commercial negotiations remain in early stages.

  • · Soluna regained compliance with Nasdaq listing requirements.
  • · A definitive joint venture agreement was signed with Metrobloks for Kati 2, replacing the prior non-binding MOU.
  • · A definitive purchase agreement was signed for 300 acres for Dorothy 3.
  • · Briscoe Wind Farm (150 MW) was successfully integrated into operations.
  • · Project Kati 1B Phase 1 (12 MW) achieved substantial completion; Phase 2 (9 MW) achieved mechanical and power commissioning; Phase 3 (14 MW) is ahead of schedule.
  • · Project Annie (74 MW) is being developed for a potential new customer; ERCOT interconnection studies are nearing completion.
  • · Tenant due diligence continues with Hyperscalers and Neoclouds; formal commercial negotiations started with at least one potential tenant for Kati 2.
  • · The company engaged a top-tier investment bank to lead capital raising for Kati 2.
  • · Transformer repair work at D1A was completed in May, returning operations to full capacity.
Wendy's Co 8-K neutral materiality 3/10

09-06-2026

Wendy's Co announced the resignation of Chief Accounting Officer Suzanne M. Thuerk, effective after a transition period ending July 10, 2026. Aaron M. Kale, formerly Vice President – Tax, has been appointed as the new Chief Accounting Officer and Vice President – Tax, effective June 8, 2026. This is a routine executive transition with no financial metrics to compare period-over-period.

  • · Suzanne Thuerk's resignation is to pursue an opportunity outside the restaurant space.
  • · Aaron Kale has been with Wendy's since July 2012, previously serving as Director – Global Income Tax Compliance, Director – International and Property Tax, and Director – International Tax.
  • · Kale had been providing interim support to the accounting function since July 2025.
  • · Kale is a certified public accountant and previously worked at L Brands and PwC.
  • · Thuerk will remain in a non-executive capacity through July 10, 2026 to assist with transition.
Rain Enhancement Technologies Holdco, Inc. 8-K neutral materiality 7/10

09-06-2026

Rain Enhancement Technologies Holdco, Inc. entered into a debt-to-equity conversion agreement with RHY Management LLC, an affiliate of Chairman Harry You, converting $4,000,000 of outstanding debt into 1,612,903 shares of Class A common stock at $2.48 per share. The company also issued 50,000 shares to its interim CFO and 490,000 shares to directors, advisors, and a consultant as compensation. Following these issuances, total outstanding Class A common stock reached 10,283,984 shares as of June 5, 2026.

  • · The conversion price was set at $2.48 per share, based on the 10-day VWAP preceding June 5, 2026.
  • · The converted debt of $4,000,000 is part of a larger outstanding debt of approximately $12,300,000 under the Loan Agreement.
  • · The original Loan Agreement included a $3,064,403.66 rollover loan and a line of credit initially set at $7,000,000, later increased to $10,000,000 as of March 31, 2026.
  • · Shares issued to RHY Management LLC are subject to a lock-up agreement until the earlier of December 31, 2026 or a liquidity event.
  • · The company relied on Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D for the unregistered sale of equity securities.
  • · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
Renatus Tactical Acquisition Corp I 8-K negative materiality 7/10

09-06-2026

On June 5, 2026, director Matan Fattal resigned from the board and all committees of Renatus Tactical Acquisition Corp I, effective immediately, with no dispute or disagreement cited. As a result, the company notified Nasdaq that it no longer meets the audit committee minimum of three members (Listing Rule 5605(c)(2)(A)) and lacks a majority of independent directors (Rule 5605(b)). The company is searching for a new independent director and intends to rely on Nasdaq's cure periods to regain compliance.

  • · Mr. Fattal resigned from the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.
  • · The company's securities trade on The Nasdaq Global Market under symbols RTACU, RTAC, and RTACW.
  • · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
  • · The company's principal executive offices are located at 1825 Ponce de Leon Blvd, Suite 260, Coral Gables, FL 33134.
STIFEL FINANCIAL CORP 8-K neutral materiality 5/10

09-06-2026

Stifel Financial Corp. filed an 8-K on June 9, 2026, announcing an amendment to its Second Restated Certificate of Incorporation to increase authorized common shares from 200 million to 291 million and authorized preferred shares from 1 million to 3 million. The amendment was approved by the board and shareholders, and executed by Chairman and CEO Ronald J. Kruszewski.

  • · The amendment increases authorized common stock from 200 million to 291 million shares and preferred stock from 1 million to 3 million shares.
  • · The amendment was adopted under Section 242 of the Delaware General Corporation Law.
  • · The filing includes items 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), 5.07 (Submission of Matters to a Vote of Security Holders), and 9.01 (Financial Statements and Exhibits).
Trade Desk, Inc. 8-K positive materiality 4/10

09-06-2026

The Trade Desk appointed David Haddad, a veteran media and entertainment executive with over 30 years of experience at Warner Bros., Activision Blizzard, Vivendi Games, Mattel, and Disney, to its board of directors. Haddad most recently served as President of WB Games at Warner Bros. Discovery. The appointment strengthens the board with operational and media expertise as the company continues to scale its advertising technology platform.

  • · Haddad holds a B.S. in Business Administration from Miami University and an M.B.A. from Harvard Business School.
  • · The Trade Desk is headquartered in Ventura, CA, with offices across North America, Europe, and Asia Pacific.
  • · The filing is an 8-K dated June 9, 2026, under Items 5.02 and 9.01.
HERSHEY CO 8-K positive materiality 4/10

09-06-2026

The Hershey Company appointed Joe Park to its Board of Directors, effective June 29, 2026. Mr. Park brings over 20 years of experience in digital transformation and technology strategy from roles at State Farm, Yum! Brands, and Walmart. He will serve on the Audit and Finance and Risk Management Committees and qualifies as an independent director under NYSE standards.

  • · Mr. Park currently serves as Executive Vice President and Chief Digital and Information Officer at State Farm, responsible for technology, data, and innovation functions.
  • · Prior roles include Chief Digital and Technology Officer at Yum! Brands, President of Byte by Yum! (an AI-driven restaurant technology platform), and Chief Digital and Technology Officer for Pizza Hut Global.
  • · Mr. Park will be compensated under the Company's non-employee director compensation program as described in the 2026 proxy statement filed March 25, 2026.
  • · No arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K exist in connection with his appointment.
Grocery Outlet Holding Corp. 8-K mixed materiality 7/10

09-06-2026

Grocery Outlet Holding Corp. announced the appointments of Paul Miller as Chief Purchasing and Merchandising Officer and Ian Ferry as Chief Financial Officer, effective June 9, 2026, as part of efforts to restore long-term profitable growth. The company also affirmed its Q2 and fiscal year 2026 financial outlook originally provided on May 13, 2026. The departures of Matt Delly and Chris Miller (retiring) accompany these changes, with Miller supporting the transition through June 26, 2026.

  • · Paul Miller is a 25+ year Grocery Outlet veteran who retired in 2024 and has been serving as an advisor to the company.
  • · Ian Ferry joined Grocery Outlet in 2025 and previously spent over two decades in finance and investing, including as a senior investment leader at Jackson Square Partners.
  • · Chris Miller will remain with the company through June 26, 2026, to support the transition.
  • · The company operates more than 540 stores across 16 states.
VerifyMe, Inc. 8-K neutral materiality 5/10

09-06-2026

VerifyMe, Inc. entered into the Second Amendment to its Merger Agreement with Open World Ltd. on June 4, 2026, revising the definition of Fully Diluted Company Shares to include shares issuable under existing equity agreements. This amendment is part of the previously disclosed merger through which Open World will become a wholly-owned subsidiary of VerifyMe.

  • · The Merger Agreement was previously disclosed and originally involved Merger Sub merging with and into Open World.
  • · The Second Amendment revises the definition of Fully Diluted Company Shares to include Open World ordinary shares issuable under any existing agreement to issue Equity Interests.
  • · The Amendment is filed as Exhibit 2.1 and incorporated by reference from the Company’s Registration Statement on Form S-4/A filed on June 8, 2026.
  • · The filing is a written communication pursuant to Rule 425 under the Securities Act.
Ingredion Inc 8-K positive materiality 9/10

09-06-2026

Ingredion announced a recommended all-cash acquisition of Tate & Lyle for a total enterprise value of approximately £3.7B ($5.0B), representing a 59% premium to Tate & Lyle's closing share price as of May 13, 2026. The deal is expected to deliver significant net cost synergies of approximately $130 million annually by 2030, with one-time integration costs of about $175 million. Completion is expected in the second half of 2027, subject to shareholder and regulatory approvals.

  • · Ingredion intends to finance the acquisition through existing cash, new debt, and a fully committed bridge facility.
  • · Pro forma net leverage at completion expected to be approximately 3.0x net debt-to-adjusted EBITDA, with a target to reduce to ~2.5x within 18 months post-completion.
  • · Tate & Lyle shareholders will also receive a final dividend of up to 13.2 pence per share for FY ended March 31, 2026, and an interim dividend of up to 6.8 pence per share for H1 ending September 30, 2026.
  • · The acquisition is expected to be adjusted EPS accretive in the first year following completion.
  • · The transaction has been unanimously approved by Ingredion's Board of Directors and is recommended unanimously by Tate & Lyle's Board.
  • · Completion is subject to Tate & Lyle shareholder approval, court sanction, and antitrust conditions.
NexPoint Residential Trust, Inc. 8-K mixed materiality 7/10

09-06-2026

NexPoint Residential Trust, Inc. (NXRT) reported Q3 2025 results with net income of $0.8 million, or $0.03 per diluted share, compared to net income of $1.3 million, or $0.05 per diluted share, in Q3 2024. Core FFO was $0.47 per diluted share, down from $0.50 in the prior year quarter. Same-store revenue increased 2.0% year-over-year, while same-store expenses rose 3.5%, resulting in a 1.0% increase in same-store NOI. The company also announced a quarterly dividend of $0.375 per share.

  • · Quarterly dividend declared of $0.375 per share.
  • · Same-store occupancy was 94.5% at quarter end.
  • · Acquired one property for $45.0 million during the quarter.
Cheniere Energy Partners, L.P. 8-K neutral materiality 7/10

09-06-2026

Cheniere Energy Partners, L.P. (CQP) entered into a Registration Rights Agreement on June 9, 2026, in connection with the issuance of $1.75 billion aggregate principal amount of senior notes: $1.0 billion of 5.350% Senior Notes due 2036 and $750 million of 6.050% Senior Notes due 2056. The agreement obligates the company to file an exchange offer registration statement within 360 days of the issue date and, under certain conditions, a shelf registration statement, providing liquidity and tradability for the notes. The notes are guaranteed by several subsidiaries, including Cheniere Energy Investments, Sabine Pass LNG entities, and Cheniere Creole Trail Pipeline.

  • · The Registration Rights Agreement was entered into as an inducement for the Purchasers to enter into the Purchase Agreement dated May 26, 2026.
  • · The notes are issued under a Base Indenture dated September 18, 2017, as supplemented by the Eleventh and Twelfth Supplemental Indentures dated June 9, 2026.
  • · The company must use commercially reasonable efforts to keep the Exchange Offer Registration Statement effective for at least 20 business days after notice is mailed to holders.
  • · If the Registered Exchange Offer is not consummated within 360 days of the issue date, or if certain other conditions are met, the company must file a Shelf Registration Statement.
  • · Holders participating in the exchange offer must represent they are acquiring the Exchange Securities in the ordinary course of business and have no arrangements to distribute them.
Mawson Infrastructure Group Inc. 8-K positive materiality 6/10

09-06-2026

Big Digital Energy, Inc. (Nasdaq: BGDE) announced the termination of its stockholder rights agreement, effective June 8, 2026, after the Board concluded it is no longer necessary. The company operates 129 MW of digital infrastructure capacity and focuses on carbon-free energy sources including nuclear power.

  • · The Rights Agreement was originally set to expire on February 1, 2027, but was accelerated to June 8, 2026.
  • · The Board unanimously approved the amendment to accelerate expiration.
  • · The company provides services for AI, HPC, digital assets (including Bitcoin mining), and other intensive compute applications.
  • · The company's strategy includes powering operations with carbon-free energy resources, including nuclear power.
  • · The company has 129 megawatts of capacity already online and more under development.
AFFILIATED MANAGERS GROUP, INC. 8-K neutral materiality 7/10

09-06-2026

Affiliated Managers Group, Inc. entered into a Fourth Amended and Restated Credit Agreement dated June 9, 2026, establishing a $1.25 billion revolving credit facility with Bank of America as administrative agent and a syndicate of lenders. The agreement amends and restates the prior Third Amended and Restated Credit Agreement dated November 15, 2024, and includes provisions for alternative currency loans, increased commitments, and various financial covenants.

  • · The credit agreement is dated June 9, 2026 and amends and restates the Third Amended and Restated Credit Agreement dated November 15, 2024.
  • · The facility includes a swingline lender and L/C issuer (Bank of America) and allows for alternative currency loans in Euro, Sterling, and Canadian Dollar.
  • · The agreement includes financial condition covenants, limitations on priority debt and liens, and events of default provisions.
Aditxt, Inc. 8-K negative materiality 8/10

09-06-2026

Aditxt, Inc. entered into a Note Purchase Agreement on June 3, 2026, issuing $725,000 in new senior secured convertible notes (plus consolidation of existing notes) to investors, with a 35% original issue discount. The subsidiary Ignite Proteomics LLC granted a security interest in substantially all its assets, and Aditxt pledged its equity in Ignite as collateral. The filing also includes representations that the company is not insolvent and has no undisclosed material adverse events, but the heavy discount and reliance on secured debt highlight significant financial strain.

  • · The new Notes consolidate $3,194,444.44 in Existing March Notes (10% OID) and $1,250,000 in Existing April Notes (25% OID).
  • · Ignite Proteomics LLC granted a security interest in substantially all its assets as collateral.
  • · Aditxt pledged its equity in Ignite Proteomics LLC as collateral.
  • · The offering is exempt from registration under Section 4(a)(2) and Rule 506(b) of Regulation D.
  • · The filing includes representations that the company is not insolvent and has no undisclosed material adverse events.
MoonLake Immunotherapeutics 8-K positive materiality 6/10

09-06-2026

MoonLake Immunotherapeutics held its 2026 Annual General Meeting on June 4, 2026, where shareholders approved all proposals, including the election of Class I director Spike Loy, ratification of Baker Tilly US, LLP as independent auditor, an advisory vote on executive compensation, and an amendment to the 2022 Equity Incentive Plan. The plan amendment increases the share reserve by 5,000,000 Class A ordinary shares, removes liberal share recycling, imposes a one-year minimum vesting requirement, and extends the plan term to June 4, 2036. All proposals received strong shareholder support, with the advisory vote on executive compensation receiving 50,365,168 votes for and only 731,158 against, indicating broad approval of the company's compensation practices.

  • · The amended plan extends the term to June 4, 2036, and incorporates a one-year minimum vesting requirement for all awards.
  • · The plan amendment removes liberal share recycling provisions and revises non-employee director compensation limits.
  • · All proposals passed with strong majorities; the lowest support was for the advisory executive compensation vote (approximately 98.6% of votes cast in favor).
  • · The company is incorporated in the Cayman Islands and its Class A ordinary shares trade on the Nasdaq Capital Market under ticker MLTX.
QuasarEdge Acquisition Corp 8-K neutral materiality 8/10

09-06-2026

QuasarEdge Acquisition Corp (NYSE: QRED) has entered into a definitive agreement to merge with Robseek Intelligence Inc., an AI-driven technology company, in a transaction implying a pre-money equity value of approximately $1 billion for Robseek. The merger will result in Robseek becoming a wholly owned subsidiary of QuasarEdge, with QuasarEdge surviving as the publicly traded company. The transaction has been approved by both boards but remains subject to regulatory and shareholder approvals, and no financial performance data for either company is disclosed in this filing.

  • · The merger structure involves Merger Sub merging into Robseek, with Robseek surviving as a wholly owned subsidiary of Purchaser, and QuasarEdge merging into Purchaser, with Purchaser surviving as the publicly traded company.
  • · Advisors: Celine & Partners, PLLC and Ogier for QuasarEdge; Torres & Zheng at Law, P.C., Harney Westwood & Riegels, and Guantao Law Firm for Robseek; Chain Stone Capital Limited (CTM) as financial advisor to Robseek.
  • · The transaction is subject to regulatory approvals, shareholder approvals of both QuasarEdge and Robseek, effectiveness of a registration statement with the SEC, and stock exchange listing approval.
  • · QuasarEdge's strategy is to partner with a business that can benefit from access to public markets and growth opportunities.
INNOVATIVE INDUSTRIAL PROPERTIES INC 8-K mixed materiality 6/10

09-06-2026

Innovative Industrial Properties, Inc. held its 2026 annual meeting on June 9, 2026, where stockholders approved the 2026 Omnibus Incentive Plan, replacing the 2016 plan, and ratified BDO USA as auditor. All five director nominees were elected, but Scott Shoemaker received significant withheld votes (6,595,430 vs. 10,281,923 for), and the advisory vote on executive compensation passed with only 10,666,254 for vs. 6,025,986 against, indicating notable shareholder dissent.

  • · The 2026 Plan replaces the Prior Plan, which was terminated as of June 9, 2026, but continues to govern outstanding awards.
  • · Proposal 3 (2026 Plan) received 13,306,826 votes for, 3,466,132 against, and 104,395 abstentions, with 4,992,391 broker non-votes.
  • · Proposal 4 (advisory vote on executive compensation) received 10,666,254 for, 6,025,986 against, and 185,113 abstentions.
  • · Proposal 5 (frequency of future advisory votes) favored 'One Year' with 16,097,437 votes.
  • · Director Scott Shoemaker had 6,595,430 votes withheld, the highest among nominees.
  • · Ratification of BDO USA passed with 21,610,111 for, 179,893 against, and 79,740 abstentions.
ARCH CAPITAL GROUP LTD. 8-K neutral materiality 7/10

09-06-2026

Arch Capital Group Ltd. completed a public offering of $2.0 billion in senior notes on June 9, 2026, consisting of $600 million of 5.250% notes due 2036 and $1.4 billion of 5.950% notes due 2056. The notes are senior unsecured obligations and are not guaranteed by any subsidiaries. Interest will be paid semi-annually starting December 15, 2026.

  • · The notes were issued under a base indenture dated May 4, 2004, supplemented by a Third Supplemental Indenture dated June 9, 2026.
  • · The 2036 notes mature on June 15, 2036; the 2056 notes mature on June 15, 2056, subject to deferral if regulatory capital requirements are not met.
  • · Redemption provisions include make-whole redemption prior to March 15, 2036 (2036 notes) and prior to December 15, 2055 (2056 notes), and par redemption on or after those dates.
  • · The notes are effectively subordinated to all secured indebtedness and to all obligations of the issuer's subsidiaries.
  • · The offering was made under a universal shelf registration statement on Form S-3 (File No. 333-275570).
Cheniere Energy, Inc. 8-K neutral materiality 7/10

09-06-2026

Cheniere Energy Partners, L.P., a subsidiary of Cheniere Energy, Inc., closed a private placement of $1.0 billion aggregate principal amount of 5.350% Senior Notes due 2036 and $750 million aggregate principal amount of 6.050% Senior Notes due 2056 on June 9, 2026. The notes are senior unsecured obligations guaranteed by certain subsidiaries and were issued under supplemental indentures to the base indenture dated September 18, 2017. The company also entered into a Registration Rights Agreement with BofA Securities, Inc. to use commercially reasonable efforts to register the notes for exchange within 360 days.

  • · The notes were issued in a private placement under Section 4(a)(2) of the Securities Act and Rule 144A/Regulation S.
  • · Interest on both tranches is payable semi-annually on May 30 and November 30, beginning November 30, 2026.
  • · The 2036 Notes mature on November 30, 2036; the 2056 Notes mature on November 30, 2056.
  • · Cheniere Partners may redeem the notes at any time prior to the Applicable Par Call Date (May 30, 2036 for 2036 Notes; May 30, 2056 for 2056 Notes) at a make-whole redemption price, and at par thereafter.
  • · The notes are senior unsecured obligations ranking equally with existing and future unsubordinated debt and senior to future subordinated debt.
  • · The Registration Rights Agreement requires Cheniere Partners to use commercially reasonable efforts to file an exchange offer registration statement within 360 days of the Issue Date, with additional interest payable for non-compliance.
Open Lending Corp 8-K neutral materiality 4/10

09-06-2026

On June 8, 2026, director William Dabbs Cavin resigned from the board of Open Lending Corp (LPRO) effective immediately. The company stated the resignation was not due to any dispute or disagreement with the company or its board regarding operations, policies, or practices.

  • · William Dabbs Cavin resigned as director effective June 8, 2026.
  • · Resignation is not the result of any dispute or disagreement with the Company or Board.
  • · Filings signed by Ben Massey, General Counsel and Corporate Secretary.
TALOS ENERGY INC. 8-K mixed materiality 6/10

09-06-2026

Talos Energy Inc. stockholders approved the Second Amended and Restated 2021 Long Term Incentive Plan (A&R LTIP) at the June 4, 2026 Annual Meeting, increasing the share reserve by 4.5 million shares to 16,939,415 shares. All director nominees were elected, and the non-binding advisory vote on named executive officer compensation for FY2025 passed with 93.5% support. However, director Paula R. Glover's term expired, reducing the board from seven to six directors, and nominee Neal P. Goldman received a notable 15.9% vote against his election.

  • · The A&R LTIP extends the plan term to the tenth anniversary of the Annual Meeting (June 4, 2036).
  • · All 16,939,415 shares are available for issuance upon exercise of incentive stock options (ISOs).
  • · Director nominee Neal P. Goldman received 120,820,103 votes for and 23,155,957 against (15.9% against).
  • · Ratification of Ernst & Young LLP as auditor passed with 149,839,839 votes for (99.6% of votes cast).
  • · The board was reduced from seven to six directors following the expiration of Paula R. Glover's term.
Ulta Beauty, Inc. 8-K neutral materiality 5/10

09-06-2026

Ulta Beauty, Inc. filed a Certificate of Amendment to its Certificate of Incorporation on June 9, 2026, amending Article Twelve to limit director and officer liability for monetary damages for breach of fiduciary duty to the extent permitted by Delaware law, and adding a new Article Fifteen establishing exclusive forum provisions for certain stockholder litigation, including derivative actions, fiduciary duty claims, DGCL claims, and Securities Act claims. The amendments were duly adopted by the Board of Directors and stockholders.

  • · The amendments were effective upon filing with the Delaware Secretary of State on June 9, 2026.
  • · Article Twelve now limits liability for both directors and officers, with 'officer' defined per Section 102(b)(7) of the DGCL.
  • · Article Fifteen designates the Court of Chancery of Delaware as the exclusive forum for derivative actions, fiduciary duty claims, DGCL claims, and internal affairs claims, and federal district courts as the exclusive forum for Securities Act claims.
  • · Any person acquiring shares is deemed to have consented to the exclusive forum provisions.
Live Oak Acquisition Corp. V 8-K neutral materiality 8/10

09-06-2026

Live Oak Acquisition Corp. V (LOKVU) entered into Non-Redemption Agreements with unaffiliated third-party shareholders to reduce redemptions in connection with its proposed business combination with Teamshares Inc. Under these agreements, shareholders agreed not to redeem 276,646 Class A ordinary shares at the extraordinary general meeting on June 16, 2026, in exchange for the Sponsor transferring 37,171 founder shares to them upon Closing. This move is expected to decrease the number of public shares redeemed, supporting deal completion, though the actual redemption level remains uncertain.

  • · Extraordinary General Meeting of Live Oak shareholders scheduled for June 16, 2026 to vote on Business Combination proposals.
  • · Non-Redemption Agreements entered into on June 5, 2026, with unaffiliated third-party shareholders (NRA Investors).
  • · Sponsor will transfer 37,171 Founder Shares to NRA Investors contemporaneously with Closing, provided NRA Investors do not exercise redemption rights.
  • · Filing contains forward-looking statements and risk factors including potential failure to obtain shareholder approval, inability to list Combined Company shares, and level of redemptions.
  • · Registration Statement on Form S-4 declared effective by SEC; Proxy Statement filed with proposals for the Meeting.
COMSCORE, INC. 8-K negative materiality 5/10

09-06-2026

On June 9, 2026, comScore, Inc. announced the departure of two senior executives: Greg Dale (Chief Operating Officer) and Frank Friedman (Head of Measurement and Chief Data and Analytics Officer), effective immediately. Their responsibilities will be assumed by CEO Matt McLaughlin. The departures may signal organizational restructuring or strategic realignment, but no financial or performance figures are disclosed in this filing.

  • · The departures are effective immediately as of June 9, 2026.
  • · CEO Matt McLaughlin will oversee the responsibilities of both departed officers.
  • · The filing does not disclose any financial impact, severance terms, or succession plans.
HWH International Inc. 8-K mixed materiality 8/10

09-06-2026

HWH International Inc. entered into a $10M PIPE with Smart Dynamics Technology Limited for 20M shares and warrants for 160M shares at $0.63 per share, and simultaneously completed a $500,000 stock purchase by majority shareholder Alset Inc. at $2.00 per share. The PIPE closing is subject to stockholder approval and Nasdaq extension, while Alset's investment closed on June 9, 2026, increasing its ownership from 79.8% to 80.5%. The transactions highlight significant insider involvement and reliance on regulatory approvals.

  • · The PIPE warrants have an exercise price of $0.63 per share and expire on the fourth anniversary of closing.
  • · The Amendment to the Securities Purchase Agreement added a closing condition requiring Nasdaq extension for continued listing compliance.
  • · Alset's investment of $500K at $2.00 per share closed on June 9, 2026.
  • · The PIPE is subject to stockholder approval by a majority of common stock holders.
  • · The securities were issued under exemption from registration under Section 4(a)(2) and Rule 506 of Regulation D.
  • · Chan Heng Fai is Chairman, CEO and majority stockholder of Alset; four other HWH board members are also Alset directors; two HWH officers are also Alset officers/directors.
NOVANTA INC 8-K positive materiality 8/10

09-06-2026

Novanta Inc. announced a $300 million private placement of 2,142,857 common shares at $140.00 per share to institutional and accredited investors, expected to close on June 11, 2026. The company also entered into a registration rights agreement for the resale of the shares. No negative or flat metrics are present in this filing.

  • · The private placement is exempt from registration under the Securities Act of 1933, and shares cannot be resold in the U.S. without an effective registration statement or exemption.
  • · The company agreed to register the resale of the common shares sold in the private placement via a registration rights agreement.
PTC THERAPEUTICS, INC. 8-K neutral materiality 2/10

09-06-2026

Alethia Young resigned from the board of directors of PTC Therapeutics on June 8, 2026, to focus on other work commitments, with no disagreement with the company. She entered a one-year consulting agreement to advise the company, receiving a monthly fee of $4,166.67. No financial results or operational changes were reported.

  • · Alethia Young's resignation was effective June 8, 2026.
  • · The consulting agreement term runs through June 8, 2027.
  • · Monthly consulting fee: $4,166.67.
  • · Ms. Young's resignation was not due to any disagreement with the company.
Nuburu, Inc. 8-K mixed materiality 8/10

09-06-2026

Nuburu, Inc. entered into a binding Head of Terms with SunCubes S.r.l. to invest up to €1,000,000 for a minority stake and establish an industrial cooperation framework for a vehicle-integrated directed-energy 'Laser Arm' system. The transaction is subject to Italian Golden Power clearance and export-control license clearance by December 30, 2026, and a capital increase condition by December 31, 2026. While the agreement opens strategic defense and energy technology opportunities, it carries significant execution risk as the definitive agreements and required clearances may not be obtained within the expected timeframe or at all.

  • · The HoT is binding and was entered into on June 4, 2026.
  • · SunCubes is an Italian developer of laser-based wireless power transmission and beam-control technologies.
  • · Current Investors are venture capital vehicles affiliated with CDP Venture Capital, which is 70% owned by CDP Equity (part of the CDP group, majority-owned by the Italian Ministry of Economy and Finance).
  • · Definitive Agreements must be entered into within 60 days of the HoT (by August 3, 2026).
  • · Clearances must be obtained by December 30, 2026, or the Definitive Agreements automatically terminate.
  • · If GP Clearance is granted only for the Industrial Cooperation Framework, parties will negotiate a joint venture structure.
  • · The Capital Increase Condition requires conversion of the Current Investors' SAFE by December 31, 2026, triggered by a third-party capital increase of at least €1,230,000 or discretionary conversion by Current Investors.
  • · If Clearances or Capital Increase Condition are not met, SunCubes must repay the Advance Payments to Nuburu by March 31, 2027.
  • · Nuburu may designate an observer to SunCubes' Board of Directors upon attainment of Clearances.
  • · SunCubes grants Nuburu a non-exclusive, fully paid-up license to certain background IP for specific fields and territories.
  • · New IP arising from integration of SunCubes products will be retained by Nuburu, with a non-exclusive license back to SunCubes.
  • · SunCubes agrees not to engage in activities related to anti-personnel mines or cluster munitions while CrossConnect or RoboIT are equity holders.
  • · Nuburu's subsidiary Lyocon (wholly owned) and Tekne (70% owned subject to GP Clearance) are identified as potential industrialization sites in Italy.
  • · The agreement includes a most-favored-customer pricing clause for Nuburu, with a potential additional discount up to 5% below the lowest price offered to other clients.

Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Material Events SEC 8-K Filings

🇺🇸 More from United States

View all →